Infant and Child European Cryoablation Project ICECaP

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorGreat Ormond Street Hospital for Children NHS Foundation Trust

About this trial

A registry to audit the current range of applications, technical success rate, safety profile, complication rate and efficacy of cryoablation procedures being performed in children.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all children in whom a clinical decision is made to treat with percutaneous cryoablation, to include those in whom cryoablation was not technically or clinically possible at any stage.

Disqualifiers

none

Trial population

All children in whom a clinical decision is made to treat with percutaneous cryoablation

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Cryoablation

    Procedure/Surgery

    Image guided cryoablation therapy of soft tissue lesions

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: children with soft tissue lesions1 intervention

Trial outcomes

Primary outcomes

1

Occurrence and severity of complications arising from cryoablation treatment

Documentation and severity scoring of any complications arising from a cryoablation procedure, using the Society of Interventional Radiology (SIR) standards of practice committee classification of complications by outcome scoring system. The range of the outcome scoring system is A-F, with A being the least severe (no therapy, no consequence), and F being the most severe (resulting death). \[Omary et al. J Vasc Interv Radiol 2003; 14:S293-S295\]

Time frame
2 years

Secondary outcomes

1

Change in maximal diameter of lesion following treatment

In patients where this is applicable, measure change in maximal lesion diameter on ultrasound or MRI imaging, comparing baseline (pre-treatment) lesion diameter to (post treatment) lesion diameter at 2 years. Subsequent lesion measurements will be made annually up to 5 years (for patients included in follow up).

Time frame
5 years
2

Change in symptomatology following treatment

Where applicable, measure change in symptomatology post treatment, as assessed by PedsQL Pediatric Quality of Life Inventory UK questionnaire version 4.0. This is a scored questionnaire used for the assessment of physical functioning, emotional functioning, social functioning and school functioning. It is completed by both the child (child report) and the parent (parent report). Each questionnaire consists of 23 items graded 0-4 where 0 equates to no functional deficit and a maximum achievable score of 92 equates to the most severe functional deficit. Combined parent and child reports are collated to give a range of scores of 0-184 per assessment.

Time frame
2 years
3

Procedure failure

This is a composite outcome defined as having the presence of any (or all) of the following: absence of consent, patient not fit for procedure, clinical complication, technical failure of equipment. This data will be collected over the 3 years of procedure recruitment into the registry.

Time frame
3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.